These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 30480822)
1. A novel multidimensional signature predicts prognosis in hepatocellular carcinoma patients. Wang S; Zhang JH; Wang H; Yang L; Hong S; Yu B; Guo JC; Liu J; Zhu YB J Cell Physiol; 2019 Jul; 234(7):11610-11619. PubMed ID: 30480822 [TBL] [Abstract][Full Text] [Related]
2. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients. Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110 [TBL] [Abstract][Full Text] [Related]
3. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911 [TBL] [Abstract][Full Text] [Related]
4. Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation. Han ZB; Zhong L; Teng MJ; Fan JW; Tang HM; Wu JY; Chen HY; Wang ZW; Qiu GQ; Peng ZH Mol Oncol; 2012 Aug; 6(4):445-57. PubMed ID: 22552153 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance. Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037 [TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma. Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356 [TBL] [Abstract][Full Text] [Related]
7. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature. Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034 [TBL] [Abstract][Full Text] [Related]
8. A novel clinical multidimensional transcriptome signature predicts prognosis in bladder cancer. Liu CP; Zhang JH; Zheng SC; Liu J; Guo JC Oncol Rep; 2018 Nov; 40(5):2826-2835. PubMed ID: 30226624 [TBL] [Abstract][Full Text] [Related]
9. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma. Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539 [TBL] [Abstract][Full Text] [Related]
10. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma. Zhang J; Chong CC; Chen GG; Lai PB PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780 [TBL] [Abstract][Full Text] [Related]
11. Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis. Qiao GJ; Chen L; Wu JC; Li ZR PeerJ; 2019; 7():e6548. PubMed ID: 30918751 [TBL] [Abstract][Full Text] [Related]
12. Significantly different expression levels of microRNAs associated with vascular invasion in hepatocellular carcinoma and their prognostic significance after surgical resection. Song SK; Jung WY; Park SK; Chung CW; Park Y PLoS One; 2019; 14(9):e0216847. PubMed ID: 31513595 [TBL] [Abstract][Full Text] [Related]
13. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
14. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm. Yang Z; Zi Q; Xu K; Wang C; Chi Q Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739 [TBL] [Abstract][Full Text] [Related]
15. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance. Yang L; Xu Q; Xie H; Gu G; Jiang J Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116 [TBL] [Abstract][Full Text] [Related]
16. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824 [TBL] [Abstract][Full Text] [Related]
17. A novel seven-lncRNA signature for prognosis prediction in hepatocellular carcinoma. Yan J; Zhou C; Guo K; Li Q; Wang Z J Cell Biochem; 2019 Jan; 120(1):213-223. PubMed ID: 30206981 [TBL] [Abstract][Full Text] [Related]
18. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma. Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620 [TBL] [Abstract][Full Text] [Related]
19. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients. Wang Z; Zhang N; Lv J; Ma C; Gu J; Du Y; Qiu Y; Zhang Z; Li M; Jiang Y; Zhao J; Du H; Zhang Z; Lu W; Zhang Y Biomed Res Int; 2020; 2020():4037639. PubMed ID: 33163533 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Liu N; Chen NY; Cui RX; Li WF; Li Y; Wei RR; Zhang MY; Sun Y; Huang BJ; Chen M; He QM; Jiang N; Chen L; Cho WC; Yun JP; Zeng J; Liu LZ; Li L; Guo Y; Wang HY; Ma J Lancet Oncol; 2012 Jun; 13(6):633-41. PubMed ID: 22560814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]